Nurse Resources

As a primary point of contact for patients, the role of the nurse is pivotal to the continuum of care. While this can be true for any patient, it is especially true for hematology patients undergoing immunotherapy.

In supporting the patient or caregiver, the nurse will assist countless times throughout the course of the patient journey. This assistance can take many forms, including discussions on disease-management options, consent, treatment, identification and monitoring of adverse events, and coordination of the multidisciplinary team. Because treatments are often administered in regional specialized centers, isolation and anxiety can add to an already uncertain future caused by a poor prognosis: The nurse becomes the patient's compass and ensures a comprehensive approach to a complex situation.

By giving more nurses greater access to the specialized immunotherapy knowledge and skills needed to actively role manage their patients, and by creating an online environment that nurtures a transparent exchange of ideas, information, and intelligence, we are helping more nurses to make a difference. We believe medical education should be for everyone. 


Immunotherapy Web Featured Images 41

The role of the coordinator nurse in the CAR-T treatment

In this video, Marlene Vercasson, from the Lyon Hospital, shares her experience in the local CAR-T program and Juliet international clinical trial. She reviews the many tasks appointed to the coordinator nurse, in adapting care to the individual patient and making contacts with the Apheresis department, Tissue and Cells Bank, Hematology...

Read more
Immunotherapy Web Featured Images 51

Do mAbs and paraprotein affect COVID-19 Serological Testing in Patients with Mul...

  Dec 04 2020 Tagged mAbs, MM, COVID-19

SARS-CoV-2 (COVID-19) serology tests do not appear to interfere or cause cross-reactivity with therapeutic monoclonal antibody (t-mAb) treatments for hematologic malignancies (HM) such as multiple myeloma (MM), according to a study published in Diagnostics.

Read more
Immunotherapy Web Featured Images 36

CAR T-Cell Therapy Improves Blood Cancer, But Toxicities Are Still Concerning

  Nov 29 2020 Tagged CAR-T, Nurses

In an interview with OncLive, during the 2020 Institutional Perspectives in Cancer webinar on Leukemia and Lymphoma, Olalekan O. Oluwole, MBBS, MD, who is an assistant professor of medicine, hematology, and oncology at Vanderbilt-Ingram Cancer Center, highlighted the evolution of CAR T-cell therapy in leukemia and lymphoma, targets under investigation, and next steps for exploration.

Visit website
Oncologynursing3

Promising Response Rates Build Excitement for CAR T-Cell Therapy in Myeloma

  Oct 31 2020 Tagged Nurses, CAR-T, MM

Anwer, an oncologist, physician-scientist, and stem cell transplant staff physician at the Taussig Cancer Center of Cleveland Clinic, discussed the growing role of CAR T-cell therapy in multiple myeloma and areas of unmet need. 

Visit website
oncologynursing1

CAR T-Cell Therapy: High Response Rates, High Toxicity Rates

Andrew D. Zelenetz, MD, PhD, medical oncologist and medical director of quality informatics at Memorial Sloan Kettering Cancer Center recently discussed CAR T-cell therapy for this patient population at the NCCN 2020 Virtual Congress on Hematologic Malignancies.

Visit website
nurse 2

Cancer immunotherapy update

Because cancer treatment (surgery, radiation, and chemotherapy) frequently fails, research­ers began asking why patients’ immune systems don’t respond to cancer cells like they do to bacteria and viruses.

Visit website
ImmunotherapyWebsite Nurses Patients 56

A Beginners Guide to Immunotherapy

In this half-day course, Dr Vickers describes the logic behind many immunotherapies for cancer such as checkpoint inhibitors and more.

Visit website
ImmunotherapyWebsite Nurses Patients 57

Immunotherapy Side Effects: What Nurses Should Look Out For

As immunotherapy evolves it is crucial that nurses know the dangerous AEs to look out for.

Visit website
ImmunotherapyWebsite Nurses Patients 71

Apheresis in adults and pediatrics

Access this patient care session on Apheresis in adults and pediatrics, by Daphna Hutt, from the 2nd European CAR T Meeting (2020).

Visit website
21

EHA Guidance Document: The Process of CAR T-Cell Therapy in Europe

This document has been created to provide practical guidance for centers and national authorities in Europe that are interested in introducing chimeric antigen receptor (CAR)-T cell therapy.

Visit website